Results 171 to 180 of about 1,854,049 (378)

Premalignant Oral Mucosal Diseases

Journal of the California Dental Association, 2001
A premalignant phase in the development of oral cancer is predicted by the classic model of experimental epithelial carcinogenesis. Virtually all oral squamous cell carcinomas arise from a premalignant precursor, but it is difficult to specifically define the term premalignant. Oral pathologists use the term epithelial dysplasia to indicate microscopic
openaire   +2 more sources

Long‐Term Clinical, Radiographic and Esthetic Outcomes of Zirconia Dental Implants: A 10‐Year Prospective Multicenter Study

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives This study aimed to prospectively investigate the long‐term clinical performance of a commercially available one‐piece zirconia dental implant system over 10 years. Material and Methods A multicenter, open‐label study was conducted at three clinical centers in Germany.
S. Roehling, K. H. Bormann, M. M. Bornstein, S. Laval, F. Thieringer, M. Gahlert   +5 more
wiley   +1 more source

Oral mucositis: a survey on changes in the proteomic profile [PDF]

, 2014
Objectives. Oral mucositis is the most severe complication of anticancer therapy. It occurs in 40-85% of patients during chemotherapy and radiotherapy but also in patients who have undergone hematopoietic stem cell transplantation.
Ardito, F., Campisi, G., Colella, G., Giannatempo, G., Lo Muzio, L.   +4 more
core  

Diagnostic Accuracy of Deep Learning Models in Detecting Peri‐Implant Marginal Bone Loss: A Systematic Review and Meta‐Analysis

Clinical Oral Implants Research, EarlyView.
ABSTRACT Background Peri‐implantitis is a common implant complication requiring early detection to prevent bone loss and implant failure. Deep learning models show promise for enhancing radiographic diagnosis. Objectives This review systematically evaluated the diagnostic performance of deep learning models in detecting peri‐implant marginal bone loss ...
Momen A. Atieh, Maanas Shah, Abeer Hakam, Fawaghi AlAli, Samhar AlSayed, Andrew Tawse‐Smith, Nabeel H. M. Alsabeeha   +6 more
wiley   +1 more source

Peri‐Implant Crevicular Fluid Analysis by Mid‐Infrared Spectroscopy in Peri‐Implantitis—A Pilot Study

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives This study aimed to assess biochemical differences in peri‐implant crevicular fluid (PICF) using ATR‐FTIR spectroscopy and multivariate analysis, through a between‐participant comparison of healthy and peri‐implantitis (PI) sites, and a within‐participant comparison of PI‐PICF and GCF from contralateral periodontal healthy teeth ...
Francisco Maligno, Ricardo N. M. J. Páscoa, Pedro S. Gomes   +2 more
wiley   +1 more source

Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review

, 2023
África Fernández Forné, M.J. García Anaya, S. Guillot, Isaac Plaza Andrade, Lourdes de la Peña Fernández, María Jesús Lorca Ocón, Yolanda Lupiáñez Pérez, María Isabel Queipo‐Ortuño, Jaime Gómez‐Millán   +8 more
openalex   +1 more source

One‐Year Analysis of Clinical and Radiological Outcomes of Two‐Piece Zirconia Compared to Titanium Implants: A Multicenter Prospective Randomized Clinical Trial

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To evaluate the clinical performance of two‐piece zirconia implants with screw‐retained abutments compared to titanium implants after 1 year of loading. Materials and Methods In this multicenter, prospective, randomized clinical trial, 61 two‐piece zirconia and 61 titanium implants were placed and restored with single crowns ...
Marc Balmer, Michael Payer, Anke Steinwender, Valentin Herber, Ronald E. Jung, Sebastian Kühl   +5 more
wiley   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

Efficacy of Episil® in patients with hematologic malignancies: a comparative study

BMC Oral Health
Background Episil® is a nonabsorbable liquid medical material used to coat and protect the mucosa in patients with oral mucositis. A few studies have reported its efficacy in patients with head and neck cancer.
Taeko Fukutani, Yukio Yoshioka, Shinpei Imori, Hirokazu Yanagihara, Kensaku Sumi, Yoshinari Myoken, Yoshinori Fujita, Souichi Yanamoto   +7 more
doaj   +1 more source

The Role of Chatbots in Enquiry‐Based Learning for Oral Health Students—An Exploratory Study

European Journal of Dental Education, EarlyView.
ABSTRACT Objective This study explores the reliability of four Chatbots in enquiry‐based learning. Four Chatbots, namely Microsoft Copilot, Google Gemini, ChatGPT 3.5 and Perplexity, were used to answer and generate questions in four specific subject areas.
Rohini Khareedi, Daniel Fernandez
wiley   +1 more source